DK1124546T3 - Anvendelse af hyaluronsyre til behandling af strålingsfremkaldt cystitis - Google Patents

Anvendelse af hyaluronsyre til behandling af strålingsfremkaldt cystitis

Info

Publication number
DK1124546T3
DK1124546T3 DK99952186T DK99952186T DK1124546T3 DK 1124546 T3 DK1124546 T3 DK 1124546T3 DK 99952186 T DK99952186 T DK 99952186T DK 99952186 T DK99952186 T DK 99952186T DK 1124546 T3 DK1124546 T3 DK 1124546T3
Authority
DK
Denmark
Prior art keywords
hyaluronic acid
radiation
treatment
induced cystitis
urinary bladder
Prior art date
Application number
DK99952186T
Other languages
Danish (da)
English (en)
Inventor
Peter J Pommerville
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Application granted granted Critical
Publication of DK1124546T3 publication Critical patent/DK1124546T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99952186T 1998-10-22 1999-10-22 Anvendelse af hyaluronsyre til behandling af strålingsfremkaldt cystitis DK1124546T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10518498P 1998-10-22 1998-10-22

Publications (1)

Publication Number Publication Date
DK1124546T3 true DK1124546T3 (da) 2004-08-09

Family

ID=22304511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99952186T DK1124546T3 (da) 1998-10-22 1999-10-22 Anvendelse af hyaluronsyre til behandling af strålingsfremkaldt cystitis

Country Status (12)

Country Link
US (2) US6667296B1 (de)
EP (1) EP1124546B1 (de)
JP (1) JP4685242B2 (de)
AT (1) ATE264674T1 (de)
AU (1) AU761158B2 (de)
CA (1) CA2347110C (de)
DE (1) DE69916643T2 (de)
DK (1) DK1124546T3 (de)
ES (1) ES2219070T3 (de)
NZ (1) NZ511068A (de)
PT (1) PT1124546E (de)
WO (1) WO2000024387A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906619D0 (en) 1999-03-23 1999-05-19 Zeneca Resins Bv Compositions
US20070173479A1 (en) * 2003-12-10 2007-07-26 Keryx Biopharmaceuticals, Inc. Methods Using Sulodexide for the Treatment of Bladder Disease
JP2007233949A (ja) * 2006-03-03 2007-09-13 Kyoto Univ 排尿管理システム
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
EP2512540B1 (de) 2009-12-15 2019-08-07 Incept, LLC Implantate und biologisch abbaubare bezugsmarkierungen
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
WO2016146573A1 (en) * 2015-03-13 2016-09-22 Repoceuticals Aps Melatonin for preventing and treating radiation cystitis
RU2676431C1 (ru) * 2018-02-26 2018-12-28 Федеральное государственное бюджетное учреждение "Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова" Министерства здравоохранения Российской Федерации (ФГБУ "РНЦРХТ им. ак. А.М. Гранова" Минздрава России) Способ моделирования лучевого цистита
EP3810125A4 (de) * 2018-06-03 2022-02-23 Glycomira Therapeutics, Inc. Verfahren zur verhinderung einer schwerwiegenden gesundheitsauswirkung und/oder gewebeschädigung nach exposition mit ionisierender strahlung und/oder chemotherapie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN181358B (de) * 1995-02-14 1998-05-30 Bioniche Inc
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
CA2154103C (en) * 1995-07-18 1998-02-24 Samuel Simon Asculai Treatment of mucous membrane disease, trauma or condition and for the relief of pain
CA2247389C (en) * 1996-12-27 2009-11-24 Seikagaku Corporation Agent for treatment of bladder troubles

Also Published As

Publication number Publication date
NZ511068A (en) 2003-10-31
AU6455899A (en) 2000-05-15
PT1124546E (pt) 2004-08-31
CA2347110C (en) 2008-08-26
EP1124546B1 (de) 2004-04-21
WO2000024387A2 (en) 2000-05-04
WO2000024387A3 (en) 2000-08-03
US20040152662A1 (en) 2004-08-05
US6667296B1 (en) 2003-12-23
EP1124546A2 (de) 2001-08-22
ES2219070T3 (es) 2004-11-16
CA2347110A1 (en) 2000-05-04
DE69916643T2 (de) 2005-04-28
DE69916643D1 (de) 2004-05-27
ATE264674T1 (de) 2004-05-15
AU761158B2 (en) 2003-05-29
JP4685242B2 (ja) 2011-05-18
JP2002528410A (ja) 2002-09-03

Similar Documents

Publication Publication Date Title
LTIP1669A (en) Cetirizine-containing antialergic solution for opthalmic or nasal use
DK1124546T3 (da) Anvendelse af hyaluronsyre til behandling af strålingsfremkaldt cystitis
ATE306251T1 (de) Verwendung eines biologisch abbaubaren polymers
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
DE69434258D1 (de) Mikroverkapselte 1,2-benzazole
IL161335A (en) Coating of stents for preventing restenosis
ATE283673T1 (de) Intravesikaler ballon
WO2002076499A3 (en) Combination treatment of pancreatic cancer
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
NO953995D0 (no) Ionenolymere som anthelmintica i dyr
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
ATE215952T1 (de) Hiv-proteaseinhibitoren
PL351710A1 (en) Anti−inflammatory therapy for inflammatory mediated infection
DK1152776T3 (da) Bionedbrydelig, injicerbar oligomer-polymer-sammensætning
BR0115882A (pt) Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
BR0008952A (pt) Composição de preparação de iodo
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
BR9915431A (pt) Composição de revestimento por eletrorrevestimento catódico
WO2000047197A3 (en) Alkylating agents for treatment of cellular proliferation
ATE425731T1 (de) Pharmazeutische zusammensetzungen eines nichtmagensaftresistenten protonenpumpen-hemmers mit einer carbonat- und bicarbonatsalzkombination
TR200101346T2 (tr) Rilüzol ve alfa-tokoferol bileşimi
Milant'ev et al. Relativistic electron acceleration by the Gaussian laser radiation; Uskorenie relyativistskikh ehlektronov gaussovym lazernym izlucheniem
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
BG108033A (en) Use of 2-amino-1-(4-hydroxy-2-methane sulphonamidophenyl)ethanol for treating urinary incontinence.